Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Jones

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 8, 2017
Structure-based design and SAR development of 5,6-dihydroimidazolo[1,5-f]pteridine derivatives as novel Polo-like kinase-1 inhibitorsAndre Kiryanov, Srinivasa Natala, Benjamin Jones, et al.
BMC Health Services Research|February 14, 2025
Co-designing the implementation of a rural health systems-strengthening rheumatic heart disease program with remote First Nations Australian communities using Theory of ChangeBenjamin Jones, Alice Mitchell, Emma Haynes, et al.
Clinical Genitourinary Cancer|April 15, 2015
Effect of African-American Race on Tumor Recurrence After Radical Cystectomy for Urothelial Carcinoma of the BladderRavi K Paluri, Charity J Morgan, David J Mooney, et al.
Inorganic Chemistry|August 14, 2010
Seleno-auranofin (Et3PAuSe-tagl): synthesis, spectroscopic (EXAFS, 197Au Mössbauer, 31P, 1H, 13C, and 77Se NMR, ESI-MS) characterization, biological activity, and rapid serum albumin-induced triethylphosphine oxide generationDavid T Hill, Anvarhusein A Isab, Don E Griswold, et al.
Cell|July 16, 2025
A postnatal molecular switch drives activity-dependent maturation of parvalbumin interneuronsMonika Moissidis, Leyla Abbasova, Martijn Selten, et al.
Trials|February 16, 2022
Minimising young children's anxiety through schools (MY-CATS): protocol for a cluster randomised controlled trial to evaluate the effectiveness and cost-effectiveness of an online parent-led intervention compared with usual school practice for young children identified as at risk for anxiety disordersTessa Reardon, Helen Dodd, Claire Hill, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Discovery of TAK-960: an orally available small molecule inhibitor of polo-like kinase 1 (PLK1)Zhe Nie, Victoria Feher, Srinivasa Natala, et al.
Health Security|February 12, 2026
Breaking Down Silos: A Multidisciplinary Approach to Mitigate Indoor Airborne Pathogen TransmissionAlex Zhu, William P Bahnfleth, Richard Bruns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2019
Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung CancerSiwen Hu-Lieskovan, Aaron Lisberg, Jesse M Zaretsky, et al.
Evidence-Based Mental Health|July 12, 2022
School-based mindfulness training in early adolescence: what works, for whom and how in the MYRIAD trial?Jesus Montero-Marin, Matthew Allwood, Susan Ball, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry Letters|February 8, 2017
Structure-based design and SAR development of 5,6-dihydroimidazolo[1,5-f]pteridine derivatives as novel Polo-like kinase-1 inhibitorsAndre Kiryanov, Srinivasa Natala, Benjamin Jones, et al.
BMC Health Services Research|February 14, 2025
Co-designing the implementation of a rural health systems-strengthening rheumatic heart disease program with remote First Nations Australian communities using Theory of ChangeBenjamin Jones, Alice Mitchell, Emma Haynes, et al.
Clinical Genitourinary Cancer|April 15, 2015
Effect of African-American Race on Tumor Recurrence After Radical Cystectomy for Urothelial Carcinoma of the BladderRavi K Paluri, Charity J Morgan, David J Mooney, et al.
Inorganic Chemistry|August 14, 2010
Seleno-auranofin (Et3PAuSe-tagl): synthesis, spectroscopic (EXAFS, 197Au Mössbauer, 31P, 1H, 13C, and 77Se NMR, ESI-MS) characterization, biological activity, and rapid serum albumin-induced triethylphosphine oxide generationDavid T Hill, Anvarhusein A Isab, Don E Griswold, et al.
Cell|July 16, 2025
A postnatal molecular switch drives activity-dependent maturation of parvalbumin interneuronsMonika Moissidis, Leyla Abbasova, Martijn Selten, et al.
Trials|February 16, 2022
Minimising young children's anxiety through schools (MY-CATS): protocol for a cluster randomised controlled trial to evaluate the effectiveness and cost-effectiveness of an online parent-led intervention compared with usual school practice for young children identified as at risk for anxiety disordersTessa Reardon, Helen Dodd, Claire Hill, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Discovery of TAK-960: an orally available small molecule inhibitor of polo-like kinase 1 (PLK1)Zhe Nie, Victoria Feher, Srinivasa Natala, et al.
Health Security|February 12, 2026
Breaking Down Silos: A Multidisciplinary Approach to Mitigate Indoor Airborne Pathogen TransmissionAlex Zhu, William P Bahnfleth, Richard Bruns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2019
Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung CancerSiwen Hu-Lieskovan, Aaron Lisberg, Jesse M Zaretsky, et al.
Evidence-Based Mental Health|July 12, 2022
School-based mindfulness training in early adolescence: what works, for whom and how in the MYRIAD trial?Jesus Montero-Marin, Matthew Allwood, Susan Ball, et al.
Pageof 13